Skip to main content
Figure 4 | Nutrition & Metabolism

Figure 4

From: Oral administration of Lactobacillus reuteri GMNL-263 improves insulin resistance and ameliorates hepatic steatosis in high fructose-fed rats

Figure 4

Lactobacillus reuteri GMNL-263 attenuates lipogenesis in high-fructose-diet rats. Effects of Lactobacillus reuteri GMNL-263 on expressions of serum lipid profiles (LDL, TG and cholesterol) (A), hepatic lipid profile (TG and cholesterol) (B), and hepatic lipogenic genes (Elvol6, FAS, and Srebp-1c) (C) in high-fructose-diet rats at 14 weeks after treatment. The results were expressed as mean ± SD (n = 6). LDL, low-density lipoprotein; TG, triglyceride; Elvol6, fatty acid elongase 6; FAS, fatty acid synthase; Srebp-1c, sterol regulatory element-binding protein 1c. #p < 0.05 compared with Control group; *p < 0.05 compared with HFD group.

Back to article page

Nutrition & Metabolism

ISSN: 1743-7075

Contact us